Global Antiglaucoma Drugs Market Drivers, Trends and Restraints 2022-2031

Antiglaucoma Drugs Market – and by Region, Opportunities and Strategies – Global Antiglaucoma Drugs Market Forecast to 2030

The Commercial Research Company Antiglaucoma Drugs Market – and by Region, Opportunities and Strategies – Global Antiglaucoma Drugs Market Forecast to 2030

Get 33% off for a limited time on our uniquely designed opportunity and strategy market research reports. Contact us today and develop winning strategies!

— The Business Research Society

LONDON, GREATER LONDON, UK, Nov. 8, 2022 / — Get 33% off for a limited time on our uniquely designed Opportunities and Strategies Market Research Reports . Contact us today and develop winning strategies!

According to the “Global Antiglaucoma Drugs Market Report 2022” by The Business Research Company, the antiglaucoma drugs market size is expected to reach a value of $6,591.8 million in 2019, after increasing at a year-on-year growth rate. compound (CAGR) of 4.2% since 2015. The market is expected to decline from $6,591.8 million in 2019 to $5,191.2 million in 2020 at a rate of -21.2%. This decline is primarily due to the lockdown and social distancing norms imposed by various countries and the economic downturn in the countries due to the COVID-19 outbreak. and measures to contain it. The market is then expected to recover and grow at a CAGR of 5.0% to reach $6,659.2 million in 2021 and to reach $7,345.6 million in 2023 at a CAGR of 2.7%. The market is expected to reach $8,089.0 million in 2025 at a CAGR of 4.9% and $10,767.9 million in 2030 at a CAGR of 5.9%. Rising incidence and prevalence of glaucoma is expected to support the growth of the anti-glaucoma drug market. ucoma is expected to support the growth of the glaucoma drugs market.

Request a sample now to better understand the Antiglaucoma Drugs Market:

Key Antiglaucoma Drugs Market Trends
The development of combination therapies for the treatment of eye diseases, including glaucoma, is an emerging trend in the anti-glaucoma drug market. Combination therapy involves the use of more than one drug or drug to treat a disease. These combination therapies reduce the frequency of eye drops or drug administration, and reduce the possibility of vascular endothelial growth factor (VEGF) expression, choroidal neovascularization, and inflammation.

Antiglaucoma Drugs Market Overview
The antiglaucoma drugs market includes sales of antiglaucoma drugs and related services by entities (organizations, individual traders, and partnerships) that produce antiglaucoma drugs to treat glaucomatous conditions. Glaucoma is a group of eye conditions that damage the optic nerve in the eye, causing blindness and impaired vision. Some of the main drugs include Xalantan, Lumigan and Travatan among others.

To learn more about the Global Antiglaucoma Drugs Market report, visit:

TBRC Global Antiglaucoma Drugs Market Report 2022 covers the following insights:
Market Size Data
• Forecast period: historical and future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
• By country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, USA.

Antiglaucoma Drugs Market Segmentation
• By type of product: alpha agonist, beta-blockers, prostaglandin analogues, combination drugs, others
• By disease type: open angle glaucoma, angle closure glaucoma, normal tension glaucoma, congenital glaucoma, other types of glaucoma
• By type of prescription: hospital prescription drugs, over-the-counter drugs
• By Geography: The global antiglaucoma drug market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest market share.

Major market players such as Allergen PLC, Novartis, Santen Pharmaceutical, Akorn, Pfizer

Trends, opportunities, strategies and much more.

The Global Antiglaucoma Drugs Market Report 2022 is one of the comprehensive reports by The Business Research Company that provides Antiglaucoma Drugs market research and insight into the global Antiglaucoma Drugs market. The market report analyzes the global Glaucoma Drugs market size, Global Glaucoma Drugs market growth drivers, Global Glaucoma Drugs market segments, Global Glaucoma Drugs market major players, glaucoma, the growth of the global glaucoma drugs market in all geographies and the revenue and market positioning of the competitors of the global glaucoma drugs market. The Global Glaucoma Drugs Market report allows you to gain insight into opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not what you were looking for? Browse similar reports from The Business Research Company:

Ophthalmic Drugs Market

Cataract Surgery Devices and Equipment Global Market Report 2022

Global Vision Care Devices and Equipment Market Report 2022

About the Business Research Company

The Business Research Company has published over 3,000 industry reports covering over 3,000 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Discover our:
TBRC Blog:
Health Blog:
Global Market Model:

Olivier Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:

Market Research Products, Services and Solutions for Your Business – TBRC

Comments are closed.